Analysts Are Downgrading These 5 Stocks

Page 5 of 5

01. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 73

Credit Suisse downgraded Pfizer Inc. (NYSE:PFE) from an outperform rating (buy) to a neutral rating (hold) on June 29. The price target has also been lowered from $47 per share to $40 per share. The analysts at Credit Suisse acknowledge that Pfizer’s valuation is attractive, and they appreciate the company’s high dividend yield compared to its peers. However, they believe that Pfizer Inc. (NYSE:PFE) will face challenges in keeping pace with its competitors in the pharmaceutical industry. This downgrade reflects Credit Suisse’s revised outlook on Pfizer Inc. (NYSE:PFE) ability to maintain its competitive position in the market.

See also 10 Undervalued Semiconductor Stocks To Buy Now and 20 Largest Semiconductor Companies in the World.

Page 5 of 5